Sequential compression biomechanical device versus primary amputation in patients with critical limb ischemia.
Affiliation1Department of Vascular and Endovascular Surgery, Western Vascular Institute, University College Hospital, Galway (UCHG), Galway, Ireland.
Local subject classificationVASCULAR DISEASE
MetadataShow full item record
CitationSequential compression biomechanical device versus primary amputation in patients with critical limb ischemia. 2013, 47 (7):532-9 Vasc Endovascular Surg
PublisherVascular and endovascular surgery
JournalVascular and endovascular surgery
AbstractIntroduction: Patients with critical limb ischemia (CLI), who are unsuitable for intervention, face the consequence of primary amputation. Sequential compression biomechanical device (SCBD) therapy provides a limb salvage option for these patients. Objectives: To assess the outcome of SCBD in patients with severe CLI who are unsuitable for revascularization. Primary end points were limb salvage and 30-day mortality. Methods: From 2005 to 2012, 189 patients with severe CLI were not suitable for revascularization. In all, 171 joined the SCBD program. We match controlled 75 primary amputations. Results: All patients were Rutherford category 4 or higher. Sustained clinical improvement was 68% at 1 year. Mean toe pressure increased from 19.9 to 35.42 mm Hg, P < .0001. Mean popliteal flow increased from 35.44 to 55.91 cm/sec, P < .0001. The 30-day mortality was 0.6%. Limb salvage was 94% at 5 years. Freedom from major adverse clinical events was 62.5%. All-cause survival was 69%. Median cost of managing a primary amputation patient is €29 815 compared to €3985 for SCBD. We treated 171 patients with artassist at a cost of €681 965. However, primary amputation for 75 patients cost €2 236 125. Conclusion: The SCBD therapy is a cost-effective and clinically effective solution in patients with CLI having no option of revascularization. It provides adequate limb salvage while providing relief of rest pain without any intervention.
- Sequential compression biomechanical device in patients with critical limb ischemia and nonreconstructible peripheral vascular disease.
- Authors: Sultan S, Hamada N, Soylu E, Fahy A, Hynes N, Tawfick W
- Issue date: 2011 Aug
- Contemporary management of critical lower limb ischemia in TASC D lesions with subintimal angioplasty in femoro-popliteal lesions, tibial angioplasty and sequential compression biomechanical device for infra-inguinal arterial occlusion. Experience and quality of life outcome learned over 25 years.
- Authors: Sultan S, Hynes N
- Issue date: 2014 Dec
- Nonoperative active management of critical limb ischemia: initial experience using a sequential compression biomechanical device for limb salvage.
- Authors: Sultan S, Esan O, Fahy A
- Issue date: 2008 May-Jun
- The Role of Sequential Pneumatic Compression in Limb Salvage in Non-reconstructable Critical Limb Ischemia.
- Authors: Zaki M, Elsherif M, Tawfick W, El Sharkawy M, Hynes N, Sultan S
- Issue date: 2016 Apr
- Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up.
- Authors: Kavros SJ, Delis KT, Turner NS, Voll AE, Liedl DA, Gloviczki P, Rooke TW
- Issue date: 2008 Mar